Anandamide Protects from Low Serum-induced Apoptosis via Its Degradation to Ethanolamine
Open Access
- 1 March 2007
- journal article
- Published by Elsevier BV
- Vol. 282 (11), 7885-7892
- https://doi.org/10.1074/jbc.m608646200
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Involvement of Cannabinoids in Cellular ProliferationMini-Reviews in Medicinal Chemistry, 2005
- Cannabinoid Receptor SignalingHandbook of Experimental Pharmacology, 2004
- Effects on Cell ViabilityHandbook of Experimental Pharmacology, 2004
- Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathwaysCell Death & Differentiation, 2004
- The endocannabinoid system and its therapeutic exploitationNature Reviews Drug Discovery, 2004
- Cannabinoids: potential anticancer agentsNature Reviews Cancer, 2003
- The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosisCell Death & Differentiation, 2003
- Anandamide Induces Apoptosis in Human Cells via Vanilloid ReceptorsPublished by Elsevier BV ,2000
- Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3FEBS Letters, 2000
- The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)British Journal of Pharmacology, 2000